These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8104882)

  • 81. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo.
    Byrne JA; Oldstone MB
    J Virol; 1984 Sep; 51(3):682-6. PubMed ID: 6332201
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Plaque forming cells: methodology and theory.
    Jerne NK; Henry C; Nordin AA; Fuji H; Koros AM; Lefkovits I
    Transplant Rev; 1974; 18():130-91. PubMed ID: 4615402
    [No Abstract]   [Full Text] [Related]  

  • 83. An antigen receptor-driven, interleukin 2-independent pathway for proliferation of murine cytolytic T lymphocyte clones.
    Moldwin RL; Lancki DW; Herold KC; Fitch FW
    J Exp Med; 1986 Jun; 163(6):1566-82. PubMed ID: 3486939
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Capacity of purified Lyt-2+ T cells to mount primary proliferative and cytotoxic responses to Ia- tumour cells.
    Sprent J; Schaefer M
    Nature; 1986 Aug 7-13; 322(6079):541-4. PubMed ID: 3090451
    [TBL] [Abstract][Full Text] [Related]  

  • 85. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites.
    Weiss WR; Sedegah M; Beaudoin RL; Miller LH; Good MF
    Proc Natl Acad Sci U S A; 1988 Jan; 85(2):573-6. PubMed ID: 2963334
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells.
    Buller RM; Holmes KL; Hügin A; Frederickson TN; Morse HC
    Nature; 1987 Jul 2-8; 328(6125):77-9. PubMed ID: 2955227
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes.
    Tsubota H; Lord CI; Watkins DI; Morimoto C; Letvin NL
    J Exp Med; 1989 Apr; 169(4):1421-34. PubMed ID: 2784486
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Lipopeptide derivatives of bacterial lipoprotein constitute potent immune adjuvants combined with or covalently coupled to antigen or hapten.
    Reitermann A; Metzger J; Wiesmüller KH; Jung G; Bessler WG
    Biol Chem Hoppe Seyler; 1989 Apr; 370(4):343-52. PubMed ID: 2757794
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Lipid modification of proteins and their membrane transport.
    Kabanov AV; Levashov AV; Alakhov VYu
    Protein Eng; 1989 Oct; 3(1):39-42. PubMed ID: 2682609
    [TBL] [Abstract][Full Text] [Related]  

  • 90. In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine.
    Deres K; Schild H; Wiesmüller KH; Jung G; Rammensee HG
    Nature; 1989 Nov; 342(6249):561-4. PubMed ID: 2586628
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Role of lymphokine-secreting CD8+ T cells in cytotoxic T lymphocyte responses against vaccinia virus.
    Mizuochi T; Hügin AW; Morse HC; Singer A; Buller RM
    J Immunol; 1989 Jan; 142(1):270-3. PubMed ID: 2521235
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Antigen recognition by class I-restricted T lymphocytes.
    Townsend A; Bodmer H
    Annu Rev Immunol; 1989; 7():601-24. PubMed ID: 2469442
    [TBL] [Abstract][Full Text] [Related]  

  • 93. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.
    Takahashi H; Cohen J; Hosmalin A; Cease KB; Houghten R; Cornette JL; DeLisi C; Moss B; Germain RN; Berzofsky JA
    Proc Natl Acad Sci U S A; 1988 May; 85(9):3105-9. PubMed ID: 2452443
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo.
    Taylor PM; Askonas BA
    Immunology; 1986 Jul; 58(3):417-20. PubMed ID: 2426185
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Activation of bone marrow-derived mouse macrophages by bacterial lipopeptide: cytokine production, phagocytosis and Ia expression.
    Hauschildt S; Hoffmann P; Beuscher HU; Dufhues G; Heinrich P; Wiesmüller KH; Jung G; Bessler WG
    Eur J Immunol; 1990 Jan; 20(1):63-8. PubMed ID: 2407539
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Presentation of exogenous antigen with class I major histocompatibility complex molecules.
    Rock KL; Gamble S; Rothstein L
    Science; 1990 Aug; 249(4971):918-21. PubMed ID: 2392683
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs.
    Takahashi H; Takeshita T; Morein B; Putney S; Germain RN; Berzofsky JA
    Nature; 1990 Apr; 344(6269):873-5. PubMed ID: 2184369
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.
    Carbone FR; Bevan MJ
    J Exp Med; 1990 Feb; 171(2):377-87. PubMed ID: 2137512
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Intracellular localization of a lipopeptide macrophage activator: immunocytochemical investigations and EELS analysis on ultrathin cryosections of bone marrow-derived macrophages.
    Uhl B; Wolf B; Schwinde A; Metzger J; Jung G; Bessler WG; Hauschildt S
    J Leukoc Biol; 1991 Jul; 50(1):10-8. PubMed ID: 2056243
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Peptide-induced antiviral protection by cytotoxic T cells.
    Schulz M; Zinkernagel RM; Hengartner H
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):991-3. PubMed ID: 1992491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.